DNMT3A and acute myeloid leukemia: Several components involved in catalysing/erasing/reading H2AK119ub1 are recurrently mutated in myeloid disorders such as AML, including ASXL1, DNMT3A, BCOR and BCORL1 (Dohner et al., 2017).